BLFS
BioLife Solutions Inc
37.70$
-0.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51.1% | -77.1% | -52.6% | 5.5% | 11.9% | 4.4% | 13.5% | -4.1% | -11.1% | -18.4% | 10.2% | 20.9% | |
| 4.2% | 5.3% | 4.5% | 3.1% | 1.7% | 6.6% | 10.5% | 10.8% | 21.6% | 18.1% | 6.7% | 4.9% | |
| 3.7% | 7.9% | 9.4% | 11.5% | 7.7% | 11.1% | 12.4% | 11.7% | 33.2% | 46.6% | 37.6% | 23.9% | |
| 7.7% | 8.5% | 43.8% | 19.9% | 11.1% | 54.8% | -2.5% | -7.5% | 150.6% | – | – | – | |
| -10.1% | -12.3% | -6.5% | 2.7% | -16.8% | -16.3% | -2.3% | -1.9% | -19.6% | 2.2% | 0.3% | -9.3% | |
| 9.5% | 22.0% | 15.3% | 1.3% | 2.5% | 2.5% | 9.6% | 7.0% | 13.6% | 9.4% | 3.9% | 20.5% | |
| -131.4% | 65.7% | 4.8% | -1.3% | -32.9% | -98.7% | -49.4% | -10.6% | -76.2% | 26.2% | 70.9% | -74.4% | |
| 1.7% | 1.6% | 1.3% | 1.0% | 2.2% | 0.0% | – | – | – | – | – | – | |
| 221.0% | 5.7% | 2.0% | 35.7% | -21.5% | 6.4% | 211.4% | – | – | – | – | – | |
| 48.5% | 46.5% | 36.5% | 8.9% | -0.3% | 3.6% | 2.0% | -2.4% | 23.4% | -0.7% | -8.0% | -10.4% | |
| 221.0% | 5.7% | 38.5% | 43.5% | 142.6% | 5.8% | 212.3% | -2.3% | 21.4% | 15.6% | -8.2% | -11.4% | |
| 38.5% | -5.7% | -9.3% | 47.7% | 121.5% | -88.4% | 174.7% | -17.3% | -66.1% | 23.5% | 72.9% | -64.8% | |
| -60.6% | -99.1% | -67.9% | 4.2% | 9.4% | 2.0% | 3.9% | -11.1% | -24.8% | -27.8% | 6.3% | 0.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.